Search

everythinglearnresearchcommunity

for

Search:↓

Men and women react differently to opioids, with hormones potentially influencing these differences.

Quercetin may help improve symptoms of polycystic ovary syndrome.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Pumpkin Seed Oil in niosomes may help treat hair loss and improve hair growth.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Bald men are not more virile and may have fewer sexual partners.

Platelet-rich plasma and stem cell therapies are accepted treatments for hair restoration, with specific protocols recommended for best results, but more standardization is needed in stem cell use.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Botanicals like green tea extract show potential for hair growth, but more research is needed.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Finasteride increases hair weight and count in men with hair loss.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

Men with testicular cancer were less likely to experience baldness and severe acne.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.